Effect of Eriocitrin Supplementation in Subjects With Intermediate

Status Completed

Clinical Trial Summary

First, it will be evaluated whether supplementation of eriocitrin reduces hyperglycemia and insulin resistance, significantly reducing the risk of diabetes. The effects of eriocitrin on the lipid profile, inflammatory, endothelial, hepatic and renal biomarkers will also be evaluated. It is expected that metabolic parameters that constitute risk factors for diabetes and associated chronic diseases are expected to be improved by supplementation with eriocitrin

Clinical Trial Description

Volunteers will be invited to appear in a 12-hour fast to measure glucose levels, glycated hemoglobin and to perform the glucose tolerance test, in addition to an individual interview to confirm eligibility according to the inclusion and exclusion criteria. The collection of blood and the glycemic curves will be carried out next to a Laboratory of Clinical Analyzes, commercial, based in the city of Araraquara. The sample number took into account variances on glycated hemoglobin with a type I error α = 0.05 and a type II error β = 0.2 (80% power) (Mohammad, 2015). The minimum sample size considering an approximately 20% dropout rate, should have 20 individuals per group. In order to ensure adequate nutrition for the nutritional and energetic needs of volunteers, an individual food plan shall be prescribed, calculated according to the DRI equations. The volunteer will be asked to complete the Food Record for three days at the 3rd, 5th, 7th, 9th and 11th week. Data analysis of energy intake, macronutrients and micronutrients will be performed through the DietBox® . The anthropometric measurements will be performed before the intervention and in the 3rd, 5th, 7th, 9th and 11th week by Nutritionist. Four samples of 30mL of fasting blood each will be obtained before the intervention, in the 4th, 8th and 12th week in the Laboratory of Clinical Analyzes. The blood will be centrifuged to obtain the serum, which will be frozen at -80 ° C until subsequent biochemical analyzes. Normality and homogeneity will be evaluated by Shapiro-Wilk test and Levine tests, respectively. The T test will be used to compare baseline time between groups. The two-way repeated-measures ANOVA will be used to compare changes within and between the eriocitrin and control groups over the 12-week period. P significant at ≤ 0.05. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03215043
Study type	Interventional
Source	São Paulo State University
Contact
Status	Completed
Phase	N/A
Start date	July 2, 2017
Completion date	February 28, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05052918` - The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes	N/A
Completed	`NCT03714646` - Beta Glucan and Acetate Production	N/A
Completed	`NCT03377244` - Healthy Body Healthy Souls in the Marshallese Population	N/A
Completed	`NCT04427982` - Dance and Diabetes/Prediabetes Self-Management	N/A
Recruiting	`NCT05008276` - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed	`NCT03480022` - Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS	Phase 3
Withdrawn	`NCT05726409` - Mobile Application to Create Healthy Food Preparation Habits for Patients With Diabetes and Prediabetes	N/A
Completed	`NCT02834078` - Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome	N/A
Completed	`NCT04902326` - Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change)	N/A
Recruiting	`NCT04168372` - Fructose: Substrate, Stimulus, or Both?	N/A
Completed	`NCT03272074` - Egg Consumption and Glycemic Control in Individuals With Pre- and Type II-diabetes	N/A
Not yet recruiting	`NCT05939349` - A Prescription for Health Equity: A Healthcare Provider-based Produce Prescription Program for People With Prediabetes and Type 2 Diabetes	N/A
Completed	`NCT04978376` - TRE With Physical Activity for Weight Management	N/A
Recruiting	`NCT03997656` - A Digital Therapy for Diabetes Prevention Among Overweight Adults in Terengganu, Malaysia	N/A
Recruiting	`NCT05166785` - BRInging the Diabetes Prevention Program to GEriatric Populations	N/A
Completed	`NCT01729078` - Dietary Interventions in Prediabetes	N/A
Completed	`NCT04507685` - Asian Indian Prediabetes Study	N/A
Completed	`NCT03292315` - Once Weekly GLP-1 in Persons With Spinal Cord Injury	Phase 4
Active, not recruiting	`NCT05353790` - Dietary Exchanges With Avocado and Mango in Pre-diabetes	N/A
Active, not recruiting	`NCT03804892` - Can Brisk Walking Combined With Ingestion of a Lipid-lowering Drug Improve Fat Metabolism in Muscle?	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of Eriocitrin Supplementation in Subjects With Intermediate Hyperglycemia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms